• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

EGCG 对 α-突触核蛋白(αS)聚集的影响及其可能结合模式的鉴定:使用分子动力学模拟的计算研究。

Influence of EGCG on α-synuclein (αS) aggregation and identification of their possible binding mode: A computational study using molecular dynamics simulation.

机构信息

State Key Laboratory of Applied Organic Chemistry, and Department of Chemistry, Lanzhou University, Lanzhou, China.

School of Pharmacy, Lanzhou University, Lanzhou, China.

出版信息

Chem Biol Drug Des. 2018 Jan;91(1):162-171. doi: 10.1111/cbdd.13067. Epub 2017 Aug 14.

DOI:10.1111/cbdd.13067
PMID:28667699
Abstract

The accumulation of intrinsically disordered α-synuclein (αS) protein that can form β-sheet-rich fibrils is linked to Parkinson's disease. (-)-Epigallocatechin-3-gallate (EGCG) is the most abundant active component in green tea and can inhibit the fibrillation of αS. The elucidation of this molecular mechanism will be helpful to understand the inhibition mechanism of EGCG to the fibrillation of αS and also to find more potential small molecules that can inhibit the aggregation of αS. In this work, to study the influence of EGCG on the structure of β-sheet-rich fibrils of αS and identification of their possible binding mode, molecular dynamics simulations of pentamer and decamer aggregates of αS in complex with EGCG were performed. The obtained results indicate that EGCG can remodel the αS fibrils and break the initial ordered pattern by reducing the β-sheet content. EGCG can also break the Greek conformation of αS by the disappeared H-bond in the secondary structure of turn. The results from our study can not only reveal the specific interaction between EGCG and β-sheet-rich fibrils of αS, but also provide the useful guidance for the discovery of other potential inhibitors.

摘要

α-突触核蛋白(αS)的无序结构积累,可形成富含β-折叠的纤维,与帕金森病有关。表没食子儿茶素没食子酸酯(EGCG)是绿茶中最丰富的活性成分,可抑制αS 的纤维形成。阐明这一分子机制将有助于理解 EGCG 抑制 αS 纤维形成的机制,并发现更多潜在的可抑制 αS 聚集的小分子。在这项工作中,为了研究 EGCG 对富含β-折叠的 αS 纤维结构的影响并确定其可能的结合模式,对 EGCG 与五聚体和十聚体 αS 聚集体的分子动力学模拟进行了研究。结果表明,EGCG 可以通过降低β-折叠含量来重塑 αS 纤维并破坏初始有序模式。EGCG 还可以通过破坏二级结构中的氢键使 αS 希腊构象消失。我们的研究结果不仅可以揭示 EGCG 与富含β-折叠的 αS 纤维之间的特定相互作用,还可以为发现其他潜在抑制剂提供有用的指导。

相似文献

1
Influence of EGCG on α-synuclein (αS) aggregation and identification of their possible binding mode: A computational study using molecular dynamics simulation.EGCG 对 α-突触核蛋白(αS)聚集的影响及其可能结合模式的鉴定:使用分子动力学模拟的计算研究。
Chem Biol Drug Des. 2018 Jan;91(1):162-171. doi: 10.1111/cbdd.13067. Epub 2017 Aug 14.
2
Exploring the influence of EGCG on the β-sheet-rich oligomers of human islet amyloid polypeptide (hIAPP1-37) and identifying its possible binding sites from molecular dynamics simulation.探讨 EGCG 对人胰岛淀粉样多肽 (hIAPP1-37)β-折叠丰富寡聚物的影响,并从分子动力学模拟中确定其可能的结合位点。
PLoS One. 2014 Apr 16;9(4):e94796. doi: 10.1371/journal.pone.0094796. eCollection 2014.
3
Structures and free energy landscapes of the A53T mutant-type α-synuclein protein and impact of A53T mutation on the structures of the wild-type α-synuclein protein with dynamics.A53T 突变型 α-突触核蛋白的结构和自由能景观以及 A53T 突变对野生型 α-突触核蛋白结构的影响与动力学。
ACS Chem Neurosci. 2013 Jul 17;4(7):1101-13. doi: 10.1021/cn400041j. Epub 2013 May 17.
4
Epigallocatechin Gallate Destabilizes α-Synuclein Fibril by Disrupting the E46-K80 Salt-Bridge and Inter-protofibril Interface.没食子儿茶素没食子酸酯通过破坏 E46-K80 盐桥和原纤维间界面使α-突触核蛋白纤维不稳定。
ACS Chem Neurosci. 2020 Dec 16;11(24):4351-4361. doi: 10.1021/acschemneuro.0c00598. Epub 2020 Nov 13.
5
Complex of EGCG with Cu(II) Suppresses Amyloid Aggregation and Cu(II)-Induced Cytotoxicity of α-Synuclein.EGCG 与 Cu(II) 复合物抑制 α-突触核蛋白的淀粉样聚集和 Cu(II)诱导的细胞毒性。
Molecules. 2019 Aug 14;24(16):2940. doi: 10.3390/molecules24162940.
6
How oxidized EGCG remodels α-synuclein fibrils into non-toxic aggregates: insights from computational simulations.氧化型 EGCG 将α-突触核蛋白原纤维重塑为无毒聚集体的机制:计算模拟的见解。
Phys Chem Chem Phys. 2023 Jul 19;25(28):19182-19194. doi: 10.1039/d3cp02261g.
7
Critical nucleus of Greek-key-like core of α-synuclein protofibril and its disruption by dopamine and norepinephrine.α-突触核蛋白原纤维中希腊钥匙样核心的关键核及其被多巴胺和去甲肾上腺素破坏。
Phys Chem Chem Phys. 2019 Dec 18;22(1):203-211. doi: 10.1039/c9cp04610k.
8
Potential of mean force and molecular dynamics study on the transient interactions between α and β synuclein that drive inhibition of α-synuclein aggregation.驱动α-突触核蛋白聚集抑制的α和β突触核蛋白之间瞬时相互作用的平均力势和分子动力学研究
J Biomol Struct Dyn. 2017 Nov;35(15):3342-3353. doi: 10.1080/07391102.2016.1254119. Epub 2016 Nov 21.
9
Methionine oxidation in α-synuclein inhibits its propensity for ordered secondary structure.α-突触核蛋白中的蛋氨酸氧化会抑制其有序二级结构的形成倾向。
J Biol Chem. 2019 Apr 5;294(14):5657-5665. doi: 10.1074/jbc.RA118.001907. Epub 2019 Feb 12.
10
Molecular determinants of the interaction of EGCG with ordered and disordered proteins.表没食子儿茶素没食子酸酯与有序和无序蛋白质相互作用的分子决定因素。
Biopolymers. 2018 Aug;109(10):e23117. doi: 10.1002/bip.23117. Epub 2018 Mar 30.

引用本文的文献

1
An approach to characterize mechanisms of action of anti-amyloidogenic compounds in vitro and in situ.一种在体外和原位表征抗淀粉样蛋白生成化合物作用机制的方法。
NPJ Parkinsons Dis. 2025 May 10;11(1):122. doi: 10.1038/s41531-025-00966-5.
2
Targeting Protein Aggregates with Natural Products: An Optional Strategy for Neurodegenerative Diseases.靶向天然产物中的蛋白质聚集体:神经退行性疾病的可选策略。
Int J Mol Sci. 2023 Jul 10;24(14):11275. doi: 10.3390/ijms241411275.
3
The Strategies of Development of New Non-Toxic Inhibitors of Amyloid Formation.
新型无毒淀粉样蛋白形成抑制剂的研发策略。
Int J Mol Sci. 2023 Feb 14;24(4):3781. doi: 10.3390/ijms24043781.
4
Interplay between epigallocatechin-3-gallate and ionic strength during amyloid aggregation.表没食子儿茶素-3-没食子酸酯与离子强度在淀粉样蛋白聚集过程中的相互作用
PeerJ. 2021 Oct 22;9:e12381. doi: 10.7717/peerj.12381. eCollection 2021.
5
Green Tea Polyphenol Epigallocatechin-Gallate in Amyloid Aggregation and Neurodegenerative Diseases.绿茶多酚表没食子儿没食子酸酯在淀粉样蛋白聚集和神经退行性疾病中的作用
Front Neurosci. 2021 Sep 14;15:718188. doi: 10.3389/fnins.2021.718188. eCollection 2021.
6
Computational Insights Into the Inhibition Mechanism of Proanthocyanidin B2 on Tau Hexapeptide (PHF6) Oligomer.原花青素B2对tau六肽(PHF6)寡聚体抑制机制的计算洞察
Front Chem. 2021 Jul 14;9:666043. doi: 10.3389/fchem.2021.666043. eCollection 2021.
7
CMT-3 targets different α-synuclein aggregates mitigating their toxic and inflammogenic effects.CMT-3 针对不同的α-突触核蛋白聚集物,减轻其毒性和致炎作用。
Sci Rep. 2020 Nov 20;10(1):20258. doi: 10.1038/s41598-020-76927-0.
8
CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson's disease.CLR01 可保护体外培养的多巴胺能神经元和帕金森病小鼠模型中的多巴胺能神经元。
Nat Commun. 2020 Sep 28;11(1):4885. doi: 10.1038/s41467-020-18689-x.
9
EGCG impedes human Tau aggregation and interacts with Tau.EGCG 抑制人 Tau 聚集并与 Tau 相互作用。
Sci Rep. 2020 Jul 28;10(1):12579. doi: 10.1038/s41598-020-69429-6.
10
Targeting α-synuclein for PD Therapeutics: A Pursuit on All Fronts.针对帕金森病治疗的α-突触核蛋白靶点:多管齐下的探索。
Biomolecules. 2020 Mar 3;10(3):391. doi: 10.3390/biom10030391.